ARTICLE | Company News
Ciphergen, Bayer deal
July 4, 2005 7:00 AM UTC
The companies partnered to identify biomarkers and develop an assay that may be used in a clinical trial of a BAYG cancer compound. CIPH, which will use its SELDI-TOF-MS technology to analyze patient ...